WakeMed
Balance Sheet
Fiscal Year Start:
Oct 1
Assets in 2024 (Year End)
$1,971,085,645
Cash & Equivalents
30%
Property, Plant, & Equipment (net)
30%
Receivables (Non-Related)
24%
Investments
8%
Other Assets
6%
Inventories
2%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$1,085,230,262
Tax-Exempt Bond Liabilities
62%
Payables & Accruals
30%
Other Liabilities
8%
Deferred Revenue
<1%
Grants Payable
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$475,607,016
$585,433,880
+23%
Receivables (Non-Related)
$484,703,168
$463,626,113
-4%
Related-Party Receivables
$0
$0
-
Inventories
$37,045,343
$33,697,670
-9%
Prepaid Expenses
$16,271,702
$17,586,650
+8%
Investments
$135,975,860
$163,934,478
+21%
Property, Plant, & Equipment (net)
$605,898,019
$584,359,096
-4%
Other Assets
$110,638,867
$122,447,758
+11%
Total Assets
$1,866,139,975
$1,971,085,645
+6%
Liabilities
2023
2024
Change
Payables & Accruals
$348,158,155
$323,701,576
-7%
Grants Payable
-
$0
-
Deferred Revenue
$808,553
$555,474
-31%
Tax-Exempt Bond Liabilities
$677,610,733
$677,154,166
0%
Custodial & Escrow Liabilities
-
$0
-
Notes Payable / Debt (Non-Related)
-
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$71,924,807
$83,819,046
+17%
Total Liabilities
$1,098,502,248
$1,085,230,262
-1%
Net assets
2023
2024
Change
Restricted Net Assets
$658,181
$339,489
-48%
Unrestricted Net Assets
$766,979,546
$885,515,894
+15%
Net assets
2023
2024
Change
Net assets
+$767,637,727
+$885,855,383
+15%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)